
Hikal Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-20 08:00:22Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Following a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s price action and technical parameters suggest a cautiously optimistic outlook amid mixed market signals.
Read More
Hikal Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals
2026-11-19 08:14:39Hikal Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement in its technical indicators and valuation metrics despite ongoing challenges in financial performance and long-term fundamentals. The upgrade, effective from 18 Nov 2026, is driven primarily by a bullish shift in technical trends and an attractive valuation profile relative to peers, offsetting concerns over weak profitability and institutional participation.
Read More
Hikal Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Market Returns
2026-11-19 08:00:51Hikal Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend as of November 2026. This change is underscored by improvements in key indicators such as the MACD and moving averages, despite some mixed signals from other oscillators. The company’s stock price has gained 2.48% on the day, reflecting renewed investor interest amid a complex technical backdrop.
Read MoreHikal Ltd Gains 8.32%: 4 Key Factors Driving the Weekly Rally
2026-11-01 15:00:07Key Events This Week 26 Oct: Downgrade to Strong Sell amid weak fundamentals and bearish technicals 27 Oct: Technical momentum shifts to sideways trend with mixed indicator signals 29 Oct: Continued price gains supported by mild bullish daily moving averages 30 Oct: Intraday high of Rs.218.05 with an 8.91% surge, signalling strong short-term momentum Week OpenRs.194.75 ...
Read More
Hikal Ltd Surges 8.9% to Day's High of Rs 218.05 — Outperforms Sector by 4.9 Percentage Points
2026-10-30 10:01:51The Sensex edged up 0.22% on 30 Oct 2026, yet Hikal Ltd surged 8.91%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 5 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a sustained momentum continuation or a technical breakout from recent consolidation.
Read More
Hikal Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-27 08:00:46Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a marginal day change of 0.05%, the stock’s technical indicators reveal a complex picture of mixed signals, underscoring the challenges investors face in navigating its current market position.
Read More
Hikal Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
2026-10-26 08:12:44Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 23 Oct 2026. This revision reflects deteriorating technical indicators, stagnant financial trends, weak quality metrics, and valuation concerns, signalling heightened risks for investors amid ongoing underperformance against benchmarks.
Read More
Hikal Ltd Technical Momentum Shifts Amid Bearish Signals and Downgrade
2026-10-26 08:00:18Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish outlook. This change is underscored by a combination of mixed technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively suggest caution for investors amid recent price declines and deteriorating market sentiment.
Read More
Hikal Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-21 08:01:17Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators present a mixed picture, with some signals pointing to bearish tendencies while others suggest mild bullishness, reflecting a complex market sentiment around the stock priced at ₹216.40 as of 21 Oct 2026.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
05-Nov-2026 | Source : BSETranscript of Earnings Call for the Quarter and half year ended September 30 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Nov-2026 | Source : BSEPursuant to Regulation 30 and 47 of the SEBI LODR Regulations- Intimation of Newspaper Publication of Financial Results Q2 FY 27
Announcement under Regulation 30 (LODR)-Press Release / Media Release
03-Nov-2026 | Source : BSEAnnouncement under Regulation 30 of SEBI LODR 2015- Press Release on the results of the Company for the quarter and half year ended September 30 2026.
Corporate Actions
No Upcoming Board Meetings
Hikal Ltd has declared 20% dividend, ex-date: 04 Sep 26
Hikal Ltd has announced 2:10 stock split, ex-date: 27 Feb 15
Hikal Ltd has announced 1:2 bonus issue, ex-date: 22 Jun 18
No Rights history available